Arctic Bioscience AS Income Statement

Financials in millions NOK. Fiscal year is January - December.

Millions NOK. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Operating Revenue	43.97	43.48	33.75	34.27	21.52	20.5
Other Revenue	1.93	0.92	0.01	0.2	0	0.1
Revenue	45.9	44.4	33.76	34.47	21.52	20.59
Revenue Growth (YoY)	43.96%	31.55%	-2.07%	60.21%	4.48%	-31.45%
Cost of Revenue	31.46	31.6	23.98	22.63	15.72	15.18
Gross Profit	14.44	12.81	9.78	11.84	5.8	5.41
Selling, General & Admin	23.71	25.95	23.51	21.69	17.26	10.76
Other Operating Expenses	25.36	29.5	29.47	21.15	25.96	15.13
Operating Expenses	54.22	60.6	58.37	46.57	45.74	27.09
Operating Income	-39.78	-47.79	-48.59	-34.73	-39.94	-21.67
Interest Expense	-5.8	-3.15	-0.99	-0	-0.34	-0.51
Interest & Investment Income	1.27	2.05	3.74	1.89	0.12	0.02
Other Non Operating Income (Expenses)	0.95	0.95	0.33	1.47	-1.78	-0.42
EBT Excluding Unusual Items	-43.36	-47.93	-45.51	-31.36	-41.94	-22.59
Other Unusual Items	-	-	-	-2.66	-0.64	-
Pretax Income	-43.36	-47.93	-45.51	-34.02	-42.58	-22.59
Net Income	-43.36	-47.93	-45.51	-34.02	-42.58	-22.59
Net Income to Common	-43.36	-47.93	-45.51	-34.02	-42.58	-22.59
Shares Outstanding (Basic)	26	25	25	24	24	14
Shares Outstanding (Diluted)	26	25	25	24	24	14
Shares Change (YoY)	2.94%	-0.26%	3.88%	0.60%	75.31%	-
EPS (Basic)	-1.66	-1.89	-1.79	-1.39	-1.75	-1.63
EPS (Diluted)	-1.66	-1.89	-1.79	-1.39	-1.75	-1.63
Free Cash Flow	-58.42	-96.17	-65.07	-83.96	-76	-35.32
Free Cash Flow Per Share	-2.24	-3.79	-2.56	-3.43	-3.12	-2.54
Gross Margin	31.45%	28.84%	28.97%	34.36%	26.95%	26.28%
Operating Margin	-86.68%	-107.63%	-143.93%	-100.75%	-185.63%	-105.25%
Profit Margin	-94.48%	-107.95%	-134.83%	-98.71%	-197.90%	-109.70%
Free Cash Flow Margin	-127.29%	-216.58%	-192.78%	-243.58%	-353.22%	-171.52%
EBITDA	-38.03	-44.9	-43.2	-31	-37.42	-20.48
EBITDA Margin	-82.87%	-101.12%	-127.99%	-89.92%	-173.92%	-99.46%
D&A For EBITDA	1.75	2.89	5.38	3.73	2.52	1.19
EBIT	-39.78	-47.79	-48.59	-34.73	-39.94	-21.67
EBIT Margin	-86.68%	-107.62%	-143.93%	-100.75%	-185.63%	-105.25%
Revenue as Reported	45.9	44.4	33.76	34.47	21.52	20.59

Source: S&P Global Market Intelligence. Standard template. Financial Sources.